Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
SSE:688336
|
CN |
|
Creditshelf AG
XETRA:CSQ
|
DE |
|
Y.A.C. Holdings Co Ltd
TSE:6298
|
JP |
|
Graphene Manufacturing Group Ltd
XTSX:GMG
|
AU |
|
B
|
Bms Birlesik Metal Sanayi ve Ticaret AS
IST:BMSTL.E
|
TR |
|
M
|
Minfeng Special Paper Co Ltd
SSE:600235
|
CN |
|
N
|
Nuvei Corp
NASDAQ:NVEI
|
CA |
|
Zhejiang Starry Pharmaceutical Co Ltd
SSE:603520
|
CN |
|
Wills Inc
TSE:4482
|
JP |
|
A
|
Automotive Stampings and Assemblies Ltd
NSE:ASAL
|
IN |
Cash Flow Statement
Cash Flow Statement
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||
| Stock-Based Compensation |
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
7
|
0
|
0
|
|
| Cash Taxes Paid |
(30)
|
(25)
|
(18)
|
(25)
|
(26)
|
(22)
|
(12)
|
(23)
|
(43)
|
(43)
|
(40)
|
|
| Change in Working Capital |
(994)
|
(731)
|
(731)
|
(602)
|
(577)
|
(584)
|
(34)
|
(211)
|
(657)
|
(487)
|
(575)
|
|
| Cash from Operating Activities |
(164)
N/A
|
39
N/A
|
45
+16%
|
233
+420%
|
208
-11%
|
284
+36%
|
(21)
N/A
|
21
N/A
|
281
+1 210%
|
218
-22%
|
329
+51%
|
|
| Investing Cash Flow | ||||||||||||
| Capital Expenditures |
(304)
|
(199)
|
(177)
|
(221)
|
(306)
|
(343)
|
69
|
8
|
(281)
|
(132)
|
(255)
|
|
| Other Items |
101
|
(399)
|
(165)
|
(695)
|
(35)
|
(3)
|
(424)
|
(467)
|
(469)
|
(542)
|
(196)
|
|
| Cash from Investing Activities |
(203)
N/A
|
(597)
-194%
|
(342)
+43%
|
(917)
-168%
|
(341)
+63%
|
(346)
-1%
|
(354)
-2%
|
(458)
-29%
|
(750)
-64%
|
(675)
+10%
|
(451)
+33%
|
|
| Financing Cash Flow | ||||||||||||
| Net Issuance of Debt |
0
|
50
|
150
|
150
|
50
|
0
|
100
|
100
|
0
|
0
|
(50)
|
|
| Cash Paid for Dividends |
0
|
0
|
(0)
|
(1)
|
(2)
|
(2)
|
(31)
|
(51)
|
(52)
|
(52)
|
(77)
|
|
| Other |
0
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
0
N/A
|
52
N/A
|
152
+191%
|
151
-1%
|
51
-67%
|
(2)
N/A
|
69
N/A
|
49
-30%
|
(52)
N/A
|
48
N/A
|
(127)
N/A
|
|
| Change in Cash | ||||||||||||
| Effect of Foreign Exchange Rates |
(1)
|
5
|
9
|
1
|
1
|
(2)
|
(2)
|
(2)
|
0
|
(1)
|
9
|
|
| Net Change in Cash |
(368)
N/A
|
(501)
-36%
|
(136)
+73%
|
(531)
-290%
|
(81)
+85%
|
(66)
+19%
|
(307)
-367%
|
(390)
-27%
|
(521)
-34%
|
(410)
+21%
|
(240)
+41%
|
|
| Free Cash Flow | ||||||||||||
| Free Cash Flow |
(468)
N/A
|
(160)
+66%
|
(132)
+18%
|
12
N/A
|
(98)
N/A
|
(59)
+40%
|
48
N/A
|
30
-38%
|
0
-99%
|
86
+24 086%
|
73
-15%
|
|